Irwin Naturals - Klee Irwin, CEO & Chairman
Klee Irwin, CEO & Chairman
Source: Irwin Naturals Inc.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Irwin Naturals (IWIN) has agreed to purchase all of the issued and outstanding shares of Ketamine Media
  • Ketamine Media is the nation’s leading growth platform for clinics offering ketamine-assisted therapy
  • The acquisition of Ketamine Media will support IWIN’s mission to bring healing to people suffering from mental health disorders
  • The total consideration at closing will be paid in cash and stock
  • Irwin Naturals develops vitamins and other health supplements and distributes these products in the United States and Canada
  • Irwin Naturals (IWIN) opened trading at C$2.10

Irwin Naturals (IWIN) has agreed to purchase all of the issued and outstanding shares of Ketamine Media. 

Keta Media, LLC, dba Ketamine Media, is the nation’s leading growth platform for clinics offering ketamine-assisted therapy. With a global network dedicated to improving patient outcomes, Keta Media has established relationships with clinics in over 45 states and three countries. It connects providers and patients using a unique patient-centred approach to communication.

Irwin Naturals CEO Klee Irwin commented on the news.

“While this transaction will contribute immediately to our profitability, this acquisition is driven predominantly by strategic considerations. Ketamine Media will support our mission to bring healing to people suffering from mental health disorders. We are in acquisition discussions with many clinics that tell us that Ketamine Media has been almost solely responsible for their growth. We are excited to have them as part of the Irwin family.”

Chris Walden, CEO of Ketamine Media, added,

“We will continue providing the high level of services our clients are accustomed to. For us, this deal will give us access to growth capital that will allow Ketamine Media to add new advisory services that will greatly benefit all our clients at a much more rapid pace. Ketamine Media wants to help encourage more collaboration within this emerging space between providers in local markets. During our discussions with Irwin Naturals, we identified a number of parallels in our belief system, including a desire to help our existing book of business to achieve the outcomes that led them to sign up with KM. We believe that Irwin Naturals will be successful in their strategy to become a leading international brand of psychedelic mental health clinics.”

The total consideration at closing will be paid in cash and stock, including the assumption of certain debts of Ketamine Media.

Irwin Naturals is a herbal supplement formulator which is now leveraging its brand to enter into both the cannabis and psychedelic industries.

Irwin Naturals (IWIN) opened trading at C$2.10.


More From The Market Herald

" Diagnos (TSXV:ADK) closes non-brokered private placement

Diagnos (ADK) has closed its non-brokered private placement for gross proceeds of $500,000.
NurExone Exosomes

" NurExone (TSXV:NRX) reports Q3 2022 financial results & provides corporate update

NurExone Biologic (NRX) reported its financial results for the quarter ended September 30, 2022.

" Wellteq (CSE:WTEQ) announces shareholder approval for plan of arrangement with AHI

Wellteq Digital Health (WTEQ) has announced that holders of its common shares have approved its plan of arrangement.

" Empower Clinics (CSE:EPW) names new General Manager of Medisure Labs

Empower Clinics (EPW) has appointed Eric Christian as the new General Manager of its medical diagnostics laboratory business, Medisure Labs.